Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | CES2 | O00748 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16568666 | 0.88 | POLB (0.49) | CYP2C19POLBRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL2053138 | 0.87 | LMNA (0.52) | CYP2C19POLBLMNACES2CES1 | |
| SCHEMBL6438569 | 0.85 | HPGD (0.47) | CYP2C19POLBRAB9ANPC1SMN1; SMN2 | |
| SCHEMBL5843726 | 0.84 | MDM4 (0.53) | CYP2C19POLBRAB9ASMN1; SMN2LMNA | |
| SCHEMBL1395462 | 0.83 | LMNA (0.52) | POLBLMNACES2CES1HPGD | |
| SCHEMBL5483965 | 0.81 | LMNA (0.53) | LMNACES2CES1HPGDALDH1A1 | |
| SCHEMBL7326944 | 0.81 | LMNA (0.53) | LMNACES2CES1HPGDALDH1A1 | |
| SCHEMBL16430980 | 0.81 | CYP2C19 (0.59) | CYP2C19POLBRAB9ANPC1SMN1; SMN2 | |
| Formic Acid SCHEMBL28872029 | 0.81 | LMNA (0.46) | CYP2C19POLBLMNACES2CES1 | |
| SCHEMBL6447139 | 0.80 | TGM2 (0.47) | SMN1; SMN2LMNACES2CES1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118090990-A | Preparation method of stable isotope labeled hypnone internal standard reagent | 谱同生物医药科技(常州)有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240115593-A1 | METHISOPRINOL COMPOSITIONS | PATEL REENA (IN) | 2024-04-11 | — | — | US | disclosed |
| US-20210332120-A1 | TRISPECIFIC ANTIBODIES AGAINST IL-17A, IL-17F AND OTHER PRO-INFLAMMATORY MOLECULE | JOINT STOCK COMPANY "BIOCAD" (RU) | 2021-10-28 | — | — | US | disclosed |
| US-11136408-B2 | Anti-PD-1 antibodies, method for producing same and method for using same | CLOSED JOINT-STOCK COMPANY "BIOCAD" (RU) | 2021-10-05 | — | — | US | disclosed |
| US-10450376-B2 | Anti-MET antibodies and compositions | SYMPHOGEN A/S (DK) | 2019-10-22 | — | — | US | disclosed |
| EP-3194444-B1 | ANTI-MET ANTIBODIES AND COMPOSITIONS | SYMPHOGEN AS (DK) | 2019-07-10 | — | — | EP | disclosed |
| EP-3486257-A1 | ANTI-PD-1 ANTIBODIES, METHOD FOR PRODUCING SAME AND METHOD FOR USING SAME | Joint Stock Company "Biocad" (RU) | 2019-05-22 | — | — | EP | disclosed |
| US-20190127478-A1 | ANTI-PD-1 ANTIBODIES, METHOD FOR PRODUCING SAME AND METHOD FOR USING SAME | CLOSED JOINT-STOCK COMPANY "BIOCAD" (RU) | 2019-05-02 | — | — | US | disclosed |
| EP-3431501-A1 | ANTI NOTCH-1 ANTIBODIES | Pfizer Inc (US) | 2019-01-23 | — | — | EP | disclosed |
| CN-109071956-A | Composition for thermoplastic elastomer and its manufacturing method and elastomer molded body | JXTG能源株式会社 | 2018-12-21 | — | — | CN | disclosed |
| EP-1291714-A1 | An aqueous thermally bleachable composition useful in a photothermographic element | EASTMAN KODAK COMPANY (US) | 2003-03-12 | — | — | EP | disclosed |
| US-6451516-B1 | AMINOPYRIDINIUM DYE WITH METHIN LINKAGE TERMINATED BY A HETEROCVYCLIC NUCLEUS AS FOUND IN CYANINE DYES | EASTMAN KODAK COMPANY | 2002-09-17 | — | — | US | disclosed |
| WO-2002011900-A1 | EXPANDABLE GRAPHITE AND METHOD | GRAFTECH INC. (US) | 2002-02-14 | — | — | WO | disclosed |
| EP-0814374-A2 | Stabilized heat-sensitive imaging material | LABELON CORPORATION (US) | 1997-12-29 | — | — | EP | disclosed |
| US-5672560-A | PHOSPHATE | LABELON CORPORATION (US) | 1997-09-30 | — | — | US | disclosed |
| EP-0679264-A4 | — | — | 1995-11-29 | — | — | EP | disclosed |
| EP-0679264-A1 | THERMAL IMAGING MATERIAL AND PREPARATION | LABELON CORPORATION (US) | 1995-11-02 | — | — | EP | disclosed |
| US-5424182-A | Mixture of a silver salt of an organic acid, reducing agents, toner and carrier | LABELON CORPORATION (US) | 1995-06-13 | — | — | US | disclosed |
| WO-1994016361-A1 | THERMAL IMAGING MATERIAL AND PREPARATION | LABELON CORPORATION (US) | 1994-07-21 | — | — | WO | disclosed |
| US-4272106-A | TRANSPARENT DYE LAYER WHICH CAN UNDERGO COLOR SHIFT IN RESPONSE TO DEVELOPER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115593-A1 | METHISOPRINOL COMPOSITIONS | INMT, MIF, CHRM1 | CYP2C19 992/4885POLB 3121/4885RAB9A 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.